Q2 2026
Read transcript →Milestone Pharmaceuticals Inc. (MIST) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$0.99
-5.33%
Mkt Cap $140.06M
Q1 2026
Read transcript →NASDAQ·Healthcare·Biotechnology
$0.99
-5.33%
Mkt Cap $140.06M
Q2 2026
Read transcript →Q1 2026
Read transcript →